Rising drug costs drove a $581 per capita increase in total medical spending for Minnesotans with private insurance last year — a trend that put a strain on household incomes and is likely to push premiums higher.
That 7% increase in 2022 followed a 12% increase in 2021, according to Thursday's annual report by MN Community Measurement. Total spending includes payments by insurers and out-of-pocket by patients.
Both numbers reflect a bounce back from 2020, when spending declined. That year, the pandemic compelled people to delay surgeries and avoid routine care at doctor' offices. But the numbers also reflect a worsening long-term trend, because spending increased more on average over the arc of the pandemic than in prior years.
Yearly spending per privately insured patient in Minnesota rose from $5,904 in 2014 to $8,832 last year, the report showed.
Some increase is inevitable, but the trajectory suggests that clinicians aren't preventing chronic diseases such as diabetes and then managing them cost effectively once they occur, said Julie Sonier, president of MN Community Measurement, a nonprofit that seeks to improve health care by publishing clinical data.
"There is a ton of room for improvement in both of these areas," she said. "We shouldn't just sit back and say, 'Well, you know, health care costs grow 5 to 6 percent a year.' I mean, they do, but that's faster than the economy historically grows."
Pharmaceutical drug costs increased 17% in 2022, when a new class of weight-loss drugs emerged.
Blue Cross and Blue Shield of Minnesota saw a 63% increase in spending on this class of drugs in the 12-month period ending in September. Hennepin Healthcare pulled coverage of those drugs for weight-loss purposes from its worker health plans for 2024 after spending millions more than expected on them in 2023.